Licensing agreement gives Elevation Oncology access to Synaffix's ADC technology for one program in combination with SYNstatin E™ Elevation Oncology nominates a novel HER3 ADC candidate EO-1022 ...
The health tech market is projected to grow from $240 billion in 2022 to $1043 billion by 2030. Technologies like EHRs, e-prescribing, and telehealth aim to simplify tasks for providers and patients.
HACKENSACK, NJ / ACCESSWIRE / January 8, 2025 / Champions Oncology, Inc. (CSBR), a leading technology-enabled oncology research organization with specialty testing services, is excited to announce ...
BOSTON--(BUSINESS WIRE)--Ontada®, a McKesson business dedicated to oncology real-world data and evidence, clinical education, and point of care technologies, today announced that it is collaborating ...
Since 2024, the Sloan Precision Oncology Institute has supported innovative precision oncology research through our research funding awards. To date, ten projects have been funded through our Ignition ...
CHICAGO--(BUSINESS WIRE)--Massive Bio, a global company specializing in AI-powered clinical trial matching and oncology data solutions, is participating in the 2025 American Society of Clinical ...
NEW YORK, March 18, 2025 /PRNewswire/ — Canopy, the first Continuous Care Platform for oncology, today announced a multi-year partnership with Texas Oncology, one of the nation’s largest ...
Artificial intelligence (AI) is revolutionizing the healthcare sector, and one of its most impactful areas of influence is oncology. From speeding up drug development to providing personalized ...
Pharmaceutical Technology on MSN
JPM26: AbbVie and RemeGen kick off deals with $5.6bn oncology agreement
AbbVie and RemeGen are the first companies to announce a deal at the J.P Morgan Healthcare Conference 2026, with more deals expected in the coming days.
Community oncology practices play a critical role in U.S. cancer care, offering high-quality, lower-cost care in the communities where patients live and work. According to the Community Oncology ...
Please provide your email address to receive an email when new articles are posted on . A viewpoint paper outlined the benefits of a well-coordinated patient-reported outcomes collection system. The ...
J&J bolstered their pipeline with new deals in 2025. Michael Vi via Shutterstock.com. CEO Joaquin Duato presented a strong outlook for Johnson & Johnson’s (J&J) revenue growth in 2026, with particular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results